Publications

Emergence of Novel Norovirus GII.4 Variant.

Chhabra, P; TULLY, DC; Mans, J; Niendorf, S; Barclay, L; Cannon, JL; Montmayeur, AM; Pan, C-Y; Page, N; Williams, R; Tutill, H; Roy, S; Celma, C; Beard, S; Mallory, ML; Manouana, GP; Velavan, TP; Adegnika, AA; Kremsner, PG; Lindesmith, LC; Hué, S; Baric, RS; Breuer, J; Vinjé, J;

2023

Emerging infectious diseases, (2023).30 1 10.3201/eid3001.231003.

The impact of Long COVID on Health-Related Quality-of-Life using OpenPROMPT.

CARLILE, O; BRIGGS, A; Henderson, A; Butler-Cole, BF C; TAZARE, J; TOMLINSON, L; MARKS, M; JIT, M; LIN, L-Y; Bates, C; Parry, J; Bacon, SC J; Dillingham, I; Dennison, W; COSTELLO, R; Walker, A; Hulme, W; GOLDACRE, B; Mehrkar, A; MacKenna, B; The OpenSAFELY Collaborative,; HERRETT, E; EGGO, R;

2023

medRxiv (2023). 10.1101/2023.12.06.23299601.

Diversity of symptom phenotypes in SARS-CoV-2 community infections observed in multiple large datasets.

Fyles, M; Vihta, K-D; Sudre, CH; Long, H; Das, R; Jay, C; Wingfield, T; Cumming, F; Green, W; Hadjipantelis, P; Kirk, J; Steves, CJ; Ourselin, S; MEDLEY, GF; Fearon, E; House, T;

2023

Scientific reports, (2023).13 1 10.1038/s41598-023-47488-9.

Reconstructing the phylodynamic history and geographic spread of the CRF01_AE-predominant HIV-1 epidemic in the Philippines from PR/RT sequences sampled from 2008 to 2018.

Polotan, FG M; Salazar, CR P; Morito, HL E; Abulencia, MF B; Pantoni, RA R; Mercado, ES; HUE, S; Ditangco, RA;

2023

Virus evolution, (2023).9 2 10.1093/ve/vead073.

Higher loss of livelihood and impoverishment in households affected by tuberculosis compared to non-tuberculosis affected households in Zimbabwe: a cross-sectional study.

TIMIRE, C; Houben, RM G J; Pedrazzoli, D; FERRAND, RA; CALDERWOOD, C; BOND, V; Mbiba, F; KRANZER, K;

2023

medRxiv (2023). 10.1101/2023.12.05.23299470.

Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform.

Ainsworth, B; Horwood, J; Walter, SR; Miller, S; Chalder, M; De Vocht, F; Denison-Day, J; Elwenspoek, MM C; Curtis, HJ; Bates, C; Mehrkar, A; Bacon, S; GOLDACRE, B; OpenSAFELY Collaborative,; Craggs, P; Amlôt, R; Francis, N; Little, P; Macleod, J; Moore, M; Morton, K; Rice, C; Sterne, J; Stuart, B; Towler, L; ... Yardley, L.

2023

Implementation science : IS, (2023).18 1 10.1186/s13012-023-01321-z.

Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities.

Zhang, H; Lai, X; Patenaude, BN; JIT, M; Fang, H;

2023

The Lancet. Public health, (2023).8 12 10.1016/S2468-2667(23)00248-7.

Quantifying climatic and socioeconomic drivers of urban malaria in Surat, India: a statistical spatiotemporal modelling study.

Santos-Vega, M; LOWE, R; Anselin, L; Desai, V; Vaishnav, KG; Naik, A; Pascual, M;

2023

The Lancet. Planetary health, (2023).7 12 10.1016/S2542-5196(23)00249-8.

Reflections On Epidemiological Modeling To Inform Policy During The COVID-19 Pandemic In Western Europe, 2020-23.

JIT, M; Ainslie, K; Althaus, C; Caetano, C; Colizza, V; Paolotti, D; Beutels, P; Willem, L; EDMUNDS, J; Nunes, B; Namorado, S; Faes, C; Low, N; Wallinga, J; Hens, N;

2023

Health affairs (Project Hope), (2023).42 12 10.1377/hlthaff.2023.00688.

Programmatic considerations for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysis. Chikungunya Virus Global Stakeholders Meeting, Panama.

Auzenbergs, M; Maure, C; Kang, H; BRADY, O; Sahastrabuddhe, S; Abbas, K;

2023

(2023).